Food News and Research

RSS

Viewpoints: The 'need' to repeal CLASS; Squaring Romney's poverty and tax promises

As a physician, I treated hundreds of patients who needed long-term care, including ones with Alzheimer's. More than 13.5 million seniors could have this disease by 2040. Middle-class families remain dangerously unprepared for these costs. Some people will likely spend more than $100,000 on care. The fictional CLASS daily benefit of $50 per day won't cover this. I urge my House and Senate colleagues to support this CLASS repeal.

19 Jan 2012

FDA to implement Abbott's STARLIMS LIMS software

Abbott announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott's STARLIMS software-based laboratory information management system (LIMS) as part of the agency's initiative to enhance FDA testing laboratories.

19 Jan 2012

Quotient's ALBAcyte Reagent Red Blood Cell products receive U.S. FDA license

Quotient Biodiagnostics, Inc., a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare institutions, is pleased to announce that its range of ALBAcyte Reagent Red Blood Cell products have been licensed for sale in the USA by the Food and Drug Administration.

19 Jan 2012

New hypothesis seeks to explain how stress can cause obesity

Stress can make you fat - and being obese can create stress. A new hypothesis seeks to explain how. Diet and lack of exercise are not sufficient to explain the worldwide rise in obesity. Stress is one of many other factors which could contribute, according to human biologist Brynjar Foss from the University of Stavanger.

19 Jan 2012

Gilead Sciences receives FDA approval for Viread to treat pediatric HIV infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12.

19 Jan 2012

EMA grants Orphan Drug Designation to Ceptaris' chlormethine gel for treatment of CTCL

Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.

18 Jan 2012

Increasing health problems from caffeinated energy drinks

A study has shown that there is a sharp rise in the number of people who report heart problems, tremors and chest pains after drinking caffeinated energy drinks. The incidences are particularly common among teenagers. Close to 300 calls were made to NSW's poisons centre regarding adverse reactions to energy drinks between January 2004 and the end of 2010, with more than a third of people attending hospital.

18 Jan 2012

Obesity in the U.S. stabilize: Report

New figures from the federal government shows that the prevalence of obesity in the U.S. largely leveled off over the last decade, even as some individual groups, such as boys from ages 6 to 19, saw increases.

18 Jan 2012

Agilent's liquid chromatography and mass spec systems listed as Class I medical devices with FDA

Agilent Technologies Inc. (NYSE:A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration.

18 Jan 2012

New pathways in battle against obesity and other lifestyle diseases

The world is encountering an epidemic of obesity, heart disease and diabetes. In the west it is already widespread and it is now exploding in the developing world with the rapid change in the lifestyles of recent generations.

18 Jan 2012

First Edition: January 18, 2012

In today's headlines, a report about the number of people in the U.S. who live in households receiving government benefits.

18 Jan 2012

Researchers identify critical cellular, molecular events that lead to esophageal adenocarcinoma

Researchers at Columbia University Medical Center (CUMC) have identified the critical early cellular and molecular events that give rise to a type of esophageal cancer called esophageal adenocarcinoma, the fastest-rising solid tumor in the United States.

18 Jan 2012

Viewpoints: Health care is a civil right; A Medicare strategy based on Lenin

Martin Luther King Jr.'s legacy is one of progress toward a better life for every American, including equal opportunity in voting, housing, education, and employment. Reflecting on his legacy also means recognizing the steps we must take to address the inequalities that persist. Many of these involve health care. Poor and minority Americans suffer from more preventable diseases on average, lower-quality care, fewer treatment options, and less health insurance coverage.

18 Jan 2012

Bioengineers receive $2 million NIH grant to develop new toxicology tests

Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.

18 Jan 2012

Alpha-1-antitrypsin may reduce effects of GVHD

A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.

18 Jan 2012

New research highlights and offers solutions for a nitrogen-soaked world

The nitrogen cycle has been profoundly altered by human activities, and that in turn is affecting human health, air and water quality, and biodiversity in the U.S., according to a multi-disciplinary team of scientists writing in the 15th publication of the Ecological Society of America's Issues in Ecology.

18 Jan 2012

Food insecurity forces families to 'stretch' infant formula

Despite receiving supplemental food benefits, some families cannot afford enough infant formula and resort to the dangerous practice of formula "stretching" - watering down formula - to feed their babies, according to a Cincinnati Children's Hospital Medical Center study conducted at urban pediatric clinics.

18 Jan 2012

Voraxaze receives FDA approval for treatment of toxic methotrexate levels

The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.

18 Jan 2012

Medtronic announces CE mark and launch of Endurant II AAA Stent Graft System

Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.

From Medtronic 17 Jan 2012

Gastric bypass superior to lap banding finds study

A new study evaluates the best option in terms of weight loss surgery for those who need it. Researchers found gastric bypass patients lose more weight than gastric banding patients and keep it off longer. Even though banding is a simpler operation, nearly half of those patients were still obese after six years.

17 Jan 2012